Engain 20 20 g Drug Premix is a Health Canada–registered veterinary drug (DIN 02426447) held by Zoetis Canada Inc, containing Ractopamine Hydrochloride. Health Canada lists its status as Cancelled Post Market (status date 04 Feb 2019). Nexara Health has matched 3 registrations of Ractopamine Hydrochloride across 2 other regulated markets.
Health Canada registration
| DIN | 02426447 |
|---|---|
| Brand name | Engain 20 |
| Active ingredient | Ractopamine Hydrochloride |
| Strength | 20 g |
| Dosage form | Drug Premix |
| Route | Oral |
| Company | Zoetis Canada Inc |
| Status | Cancelled Post Market — 04 Feb 2019 |
| Class | Veterinary |
| ATC | |
| AHFS | |
| Regulator record | Health Canada DPD entry · Product monograph |
Ractopamine Hydrochloride registered in other markets
3 registrations of the same molecule in 2 national registries outside Canada. Each row is taken from the regulator's own published list; status is shown as the registry reports it.
| Country | Product | Marketing authorisation holder | Strength | Form | Status | Registry |
|---|---|---|---|---|---|---|
| Hong Kong | Paylean 20 Premix Powder 2% (Vet) | Dch Auriga (Hong Kong) Limited - Universal Division | Registered | DH Drug Office | ||
| United States | Ractopamine hydrochloride | Alivira Animal Health Limited | Powder | FDA NDC | ||
| United States | Ractopamine Hydrochloride | Sterling Pharma Solutions Limited | Suspension | FDA NDC |
See every manufacturer of Ractopamine Hydrochloride worldwide →
Sourcing through Nexara Health
Nexara Health is a Health Canada–licensed wholesaler (DEL #3-002896) in Winnipeg. This DIN is not currently marketed in Canada. The registrations above show which regulated markets hold an equivalent presentation that can be sourced for clinical comparator use or on a named-patient basis under Health Canada's Special Access Programme. Request a quote or read how named-patient and foreign-pack supply works in Canada.
Frequently asked questions
Is Engain 20 (DIN 02426447) marketed in Canada?
No. Health Canada lists DIN 02426447 as Cancelled Post Market as of 04 Feb 2019.
Who holds the Canadian licence for this product?
Zoetis Canada Inc is the company of record in the Health Canada Drug Product Database.
Is Ractopamine Hydrochloride registered outside Canada?
Yes — Nexara Health has matched 3 registrations in 2 other markets (see the table above).
Where does this data come from?
Health Canada Drug Product Database (DPD), DIN 02426447, status date 2019-02-04; national medicine registries: DH Drug Office, FDA NDC. Nexara Health re-checks these sources weekly and shows the last verification date at the top of the page.
Source: Health Canada Drug Product Database (DPD), DIN 02426447, status date 2019-02-04; national medicine registries: DH Drug Office, FDA NDC.
Health Canada Drug Product Database (DPD), DIN 02426447, status date 2019-02-04; national medicine registries: DH Drug Office, FDA NDC. Last reviewed 2026-09-16. Nexara Health is a licensed wholesaler and supplies licensed entities only; consumer orders are routed to a partner pharmacy.